These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34791279)

  • 1. BSAC Vanguard Series: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries.
    Berman D; Neale R
    J Antimicrob Chemother; 2021 Dec; 77(1):3-4. PubMed ID: 34791279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BSAC Vanguard Report Series: The future of drug development.
    Piddock LJV
    J Antimicrob Chemother; 2022 Feb; 77(3):543-544. PubMed ID: 35195693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BSAC Vanguard Series: The future of antibiotic stewardship-managing access and excess.
    Goff D
    J Antimicrob Chemother; 2022 Mar; 77(4):863-864. PubMed ID: 34849980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BSAC Vanguard Series: Tracking the global rise of antimicrobial resistance.
    Murray CJL
    J Antimicrob Chemother; 2022 Sep; 77(10):2586-2587. PubMed ID: 35929641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BSAC Vanguard Series: The future role of laboratories in relation to antimicrobial resistance.
    Wells D
    J Antimicrob Chemother; 2022 Mar; 77(4):867-868. PubMed ID: 35022747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BSAC Vanguard Series: Antimicrobial resistance and the future of diagnostic testing.
    Hayward G; Turner P
    J Antimicrob Chemother; 2022 Feb; 77(3):547-548. PubMed ID: 34849950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care diagnostics for infection and antimicrobial resistance in sub-Saharan Africa: A narrative review.
    Hermans LE; Centner CM; Morel CM; Mbamalu O; Bonaconsa C; Ferreyra C; Lindahl O; Mendelson M
    Int J Infect Dis; 2024 May; 142():106907. PubMed ID: 38141961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility.
    Sharma A; Singh A; Dar MA; Kaur RJ; Charan J; Iskandar K; Haque M; Murti K; Ravichandiran V; Dhingra S
    J Infect Public Health; 2022 Feb; 15(2):172-181. PubMed ID: 34972026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BSAC Vanguard Series: the future of ADVOCACY on AMR.
    Osterholm MT
    J Antimicrob Chemother; 2021 Dec; 77(1):1-2. PubMed ID: 34792141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BSAC Vanguard Series: Behavioural science and antimicrobial resistance.
    Brazier A; Merriam S; Halpern D
    J Antimicrob Chemother; 2022 Jun; 77(7):1793-1795. PubMed ID: 35574722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSAC Vanguard Series: Inequality and antibiotic resistance.
    Mendelson M
    J Antimicrob Chemother; 2022 Feb; 77(2):277-278. PubMed ID: 35107142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressing Antimicrobial Resistance Sensing Technologies across Human, Animal, and Environmental Health Domains.
    Fitzpatrick KJ; Rohlf HJ; Sutherland TD; Koo KM; Beckett S; Okelo WO; Keyburn AL; Morgan BS; Drigo B; Trau M; Donner E; Djordjevic SP; De Barro PJ
    ACS Sens; 2021 Dec; 6(12):4283-4296. PubMed ID: 34874700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to address antimicrobial resistance: an ethical analysis of key tensions and how they apply in low- income and middle-income countries.
    Pokharel S; Adhikari B; Johnson T; Cheah PY
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38569658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Should We Manage Antimicrobial Resistance in Resource-Limited Settings?
    Gulleen EA; Lubwama M
    AMA J Ethics; 2024 May; 26(5):E373-379. PubMed ID: 38700521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.
    Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C
    Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
    Mahadi AR
    Front Public Health; 2021; 9():770593. PubMed ID: 34976929
    [No Abstract]   [Full Text] [Related]  

  • 18. BSAC Vanguard Series: Are we finally finding our voice on antimicrobial resistance?
    Davies DS
    J Antimicrob Chemother; 2022 Feb; 77(2):281-282. PubMed ID: 34849978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bottom-up view of antimicrobial resistance transmission in developing countries.
    Ikhimiukor OO; Odih EE; Donado-Godoy P; Okeke IN
    Nat Microbiol; 2022 Jun; 7(6):757-765. PubMed ID: 35637328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
    Shrestha P; Cooper BS; Coast J; Oppong R; Do Thi Thuy N; Phodha T; Celhay O; Guerin PJ; Wertheim H; Lubell Y
    Antimicrob Resist Infect Control; 2018; 7():98. PubMed ID: 30116525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.